◆Genexine=Decision to dispose of shares in Chinese biotech company I-Mab worth 36 billion KRW for the purpose of funding major pipeline clinical development and operations
◆Iruda=Entered into a trust contract with KB Securities for the acquisition of treasury shares worth 1 billion KRW
Hot Picks Today
"I Wish I Could Get Some Sleep" Frozen Meals an...
- The Quoted 800,000 Won, the Bill Was 5 Million... Bereaved Families of 'No-Funer...
- Samsung Electronics Faces Production Disruption: Foundry Output Plunges 58% on D...
- "You Can Only Have This in Korea": Which National Museum Cafe Menu Is Captivatin...
- "Never Hike Alone as a Woman" "Even Two Are at Risk"... Growing Fear of Crime on...
◆Webs=KOSDAQ Market Headquarters requested an inquiry disclosure related to significant market fluctuations
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
